000212410 001__ 212410
000212410 005__ 20240229154906.0
000212410 0247_ $$2doi$$a10.1007/s00066-023-02049-x
000212410 0247_ $$2pmid$$apmid:36662238
000212410 0247_ $$2ISSN$$a0179-7158
000212410 0247_ $$2ISSN$$a1439-099X
000212410 037__ $$aDKFZ-2023-00129
000212410 041__ $$aGerman
000212410 082__ $$a610
000212410 1001_ $$aDeng, Maximilian Y$$b0
000212410 245__ $$aAssociation of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma.[Verlängerung des Gesamtüberlebens durch die Impfung von autologen tumorlysatbeladenen dendritischen Zellen (DCVax-L) bei Patienten mit neu diagnostiziertem und rezidivierendem Glioblastom].
000212410 260__ $$aHeidelberg$$bSpringer Medizin$$c2023
000212410 3367_ $$2DRIVER$$aarticle
000212410 3367_ $$2DataCite$$aOutput Types/Journal article
000212410 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1677575178_27831
000212410 3367_ $$2BibTeX$$aARTICLE
000212410 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000212410 3367_ $$00$$2EndNote$$aJournal Article
000212410 500__ $$a2023 Mar;199(3):327-329
000212410 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000212410 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000212410 7001_ $$0P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDebus, Jürgen$$b1$$udkfz
000212410 7001_ $$aKönig, Laila$$b2
000212410 773__ $$0PERI:(DE-600)2003907-4$$a10.1007/s00066-023-02049-x$$gp. s00066-023-02049-x$$n3$$p327-329$$tStrahlentherapie und Onkologie$$v199$$x0179-7158$$y2023
000212410 909CO $$ooai:inrepo02.dkfz.de:212410$$pVDB
000212410 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000212410 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000212410 9141_ $$y2023
000212410 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2022-11-11$$wger
000212410 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2022-11-11$$wger
000212410 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-11
000212410 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-11
000212410 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-11
000212410 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-28
000212410 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-28
000212410 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-28
000212410 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-28
000212410 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-28
000212410 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-28
000212410 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSTRAHLENTHER ONKOL : 2022$$d2023-08-28
000212410 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-08-28
000212410 9201_ $$0I:(DE-He78)E050-20160331$$kE050$$lE050 KKE Strahlentherapie$$x0
000212410 980__ $$ajournal
000212410 980__ $$aVDB
000212410 980__ $$aI:(DE-He78)E050-20160331
000212410 980__ $$aUNRESTRICTED